Dupilumab
Products in Health Canada’s databases that list Dupilumab as a medicinal or active ingredient. Its salts and forms that the databases name on their own have their own pages.
- Drug products
- 5
- 4 authorized now
- Natural health products
- 0
- 0 active licences
- Notices of Compliance
- 30
- Products in all
- 5
Drug products
Authorized products first.
| Name | DIN | Status | Holder | Status since |
|---|---|---|---|---|
| DUPIXENT (300 MG) | 02470365 | Marketed | Sanofi-Aventis Canada Inc. | |
| DUPIXENT (200 MG) | 02492504 | Marketed | Sanofi-Aventis Canada Inc. | |
| DUPIXENT (300 MG) | 02510049 | Marketed | Sanofi-Aventis Canada Inc. | |
| DUPIXENT (200 MG) | 02524252 | Marketed | Sanofi-Aventis Canada Inc. | |
| DUPIXENT (100 MG) | 02526190 | Cancelled Pre Market | Sanofi-Aventis Canada Inc. |
Notices of Compliance
Approvals of drug submissions that list it, newest first.
- DUPIXENTOctober 6, 2026 · NOC 38414
- DUPIXENTSeptember 23, 2026 · NOC 38334
- DUPIXENTMarch 5, 2026 · NOC 37161
- DUPIXENTOctober 27, 2025 · NOC 36299
- DUPIXENTOctober 21, 2025 · NOC 36227
- DUPIXENTAugust 15, 2025 · NOC 35849
- DUPIXENTNovember 18, 2024 · NOC 34439
- DUPIXENTSeptember 6, 2024 · NOC 33967
- DUPIXENTMarch 14, 2024 · NOC 32886
- DUPIXENTMarch 12, 2024 · NOC 32866
- DUPIXENTJuly 12, 2023 · NOC 31201
- DUPIXENTJune 12, 2023 · NOC 30974
- DUPIXENTMay 1, 2023 · NOC 30889
- DUPIXENTApril 14, 2023 · NOC 30660
- DUPIXENTMay 5, 2022 · NOC 28108
- DUPIXENTMarch 25, 2022 · NOC 27827
- DUPIXENTMarch 9, 2022 · NOC 27737
- DUPIXENTJanuary 13, 2022 · NOC 27392
- DUPIXENTAugust 17, 2021 · NOC 26487
- DUPIXENTJune 24, 2021 · NOC 26199
- DUPIXENTMarch 24, 2021 · NOC 25515
- DUPIXENTFebruary 22, 2021 · NOC 25261
- DUPIXENTJanuary 20, 2021 · NOC 25048
- DUPIXENTDecember 23, 2020 · NOC 24897
- DUPIXENTNovember 12, 2020 · NOC 24600
- DUPIXENTOctober 23, 2020 · NOC 24494
- DUPIXENTAugust 12, 2020 · NOC 24044
- DUPIXENTSeptember 25, 2019 · NOC 22687
- DUPIXENTSeptember 4, 2019 · NOC 22604
- DUPIXENTNovember 30, 2017 · NOC 20101